94-31646. Controlled Substances: Established Revised 1994 Aggregate Production Quota  

  • [Federal Register Volume 59, Number 247 (Tuesday, December 27, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-31646]
    
    
    [[Page Unknown]]
    
    [Federal Register: December 27, 1994]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    Drug Enforcement Administration
    [DEA No. 125F]
    
     
    
    Controlled Substances: Established Revised 1994 Aggregate 
    Production Quota
    
    AGENCY: Drug Enforcement Administration (DEA), Justice.
    
    ACTION: Notice of a final revised aggregate production quota for 1994.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The interim notice (59 FR 54629, November 1, 1994) which 
    established a revised 1994 aggregate production quota for morphine, a 
    Schedule II controlled substance, as required under the Controlled 
    Substances Act (CSA) (21 U.S.C. 826), is adopted without change.
    
    EFFECTIVE DATE: This order is effective upon December 27, 1994.
    
    FOR FURTHER INFORMATION CONTACT: Howard McClain, Jr., Chief, Drug & 
    Chemical Evaluation Section, Drug Enforcement Administration, 
    Washington, D.C. 20537, Telephone: (202) 307-7183.
    
    SUPPLEMENTARY INFORMATION: Section 306 of the Controlled Substances Act 
    (21 U.S.C. 826) requires the Attorney General to establish aggregate 
    production quotas for controlled substances in Schedules I and II each 
    year. This responsibility has been delegated to the Administrator of 
    the DEA pursuant to Section 0.100 of Title 28 of the Code of Federal 
    Regulations. The Administrator, in turn, has redelegated this function 
    to the Deputy Administrator pursuant to 59 FR 23637 (May 6, 1994).
        On November 1, 1994, an interim notice establishing a revised 1994 
    aggregate production quota for morphine was published in the Federal 
    Register (59 FR 54629). All interested persons were invited to comment 
    on or object to this proposed aggregate production quota on or before 
    December 1, 1994. No comments or objections were received. The interim 
    notice is adopted without change.
        The Office of Management and Budget has determined that notices of 
    aggregate production quotas are not subject to centralized review under 
    Executive Order 12866. This action has been analyzed in accordance with 
    the principles and criteria contained in Executive Order 12612, and it 
    has been determined that this matter does not have sufficient 
    federalism implications to warrant the preparation of a Federalism 
    Assessment.
        The Deputy Administrator hereby certifies that this action will 
    have no significant impact upon small entities whose interests must be 
    considered under the Regulatory Flexibility Act, 5 U.S.C. 601, et seq. 
    The establishment of annual aggregate production quotas for Schedules I 
    and II controlled substances is mandated by law and by international 
    treaty obligations. While aggregate production quotas are of primary 
    importance to large manufacturers, their impact upon small entities is 
    neither negative nor beneficial. Accordingly, the Deputy Administrator 
    has determined that this action does not require a regulatory 
    flexibility analysis.
        Therefore, under the authority vested in the Attorney General by 
    Section 306 of the Controlled Substances Act of 1970 (21 U.S.C. 826), 
    delegated to the Administrator of the DEA by Section 0.100 of Title 28 
    of the Code of Federal Regulations, and redelegated to the Deputy 
    Administrator, pursuant to 59 FR 23637 (May 6, 1994), the Deputy 
    Administrator hereby orders that the 1994 revised aggregate production 
    quota for morphine, expressed in grams of anhydrous base, be 
    established as follows:
    
    ------------------------------------------------------------------------
                                                       Established revised  
                      Basic class                     1994 quota (in grams) 
    ------------------------------------------------------------------------
    Morphine.......................................                7,800,000
    ------------------------------------------------------------------------
    
        Dated: December 20, 1994.
    Stephen H. Greene,
    Deputy Administrator.
    [FR Doc. 94-31646 Filed 12-23-94; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Effective Date:
12/27/1994
Published:
12/27/1994
Department:
Drug Enforcement Administration
Entry Type:
Uncategorized Document
Action:
Notice of a final revised aggregate production quota for 1994.
Document Number:
94-31646
Dates:
This order is effective upon December 27, 1994.
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: December 27, 1994, DEA No. 125F